Amicus Therapeutics, Inc.
(Public, NASDAQ:FOLD) Watch this stockFind more results for
FOLD
Advertisement
Events
Nov 17, 2009
Lazard Capital Healthcare Conference
Oct 29, 2009
Q3 2009 Earnings Conference Call
Oct 29, 2009
Q3 2009 Earnings Release
Sep 14, 2009
Morgan Stanley Global Healthcare Conference -
|
More events from AOL Finance »
|
Key stats and ratios
| Q2 (Jun '09) | 2008 | |
| Net profit margin | -254.11% | -262.95% |
| Operating margin | -258.37% | -293.69% |
| EBITD margin | - | -283.71% |
| Return on average assets | -48.56% | -26.60% |
| Return on average equity | -100.35% | -45.15% |
| Employees | 115 | - |
Address
Website links
Company website:
http://www.amicustherapeutics.com/
http://www.amicustherapeutics.com/
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Amicus Therapeutics, Inc. discussed on blogs
Warmist conspiracy exposed? | Herald Sun Andrew Bolt Blog
- Andrew Bolt
- Andrew Bolt
- Nov 20, 2009
Amicus Therapeutics, Inc. discussions
View all discussions »Description
Amicus Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. The Company’s products in development are Amigal (migalastat hydrochloride) for Fabry disease, Plicera (isofagomine tartrate) for Gaucher disease and AT2220 (1-deoxynojirimycin HCl) for Pompe disease. The Company completed its Phase II clinical trials of Amigal and are conducting Phase II clinical trials of Plicera and AT2220.
Officers and directors
| Donald J. Hayden Jr. | Chairman of the Board | |
| John F. Crowley | President, Chief Executive Officer, Director | |
| John M. McAdam | Principal Accounting & PFO, Senior Director - Finance & Accounting , Treasurer, Corporate Controller | |
| Matthew R. Patterson | Chief Operating Officer | |
| Geoffrey P. Gilmore | Senior Vice President, General Counsel, Secretary | |
| S. Nicole Schaeffer | Senior Vice President - Human Resources and Leadership Development | |
| David Palling Ph.D. | Senior Vice President - Technical Operations | |
| Bradley L. Campbell | Vice President - Business Operations | |
| John R. Kirk | Vice President - Regulatory Affairs | |
| Andrew Shenker M.D., Ph.D. | Vice President - Clinical Research |
